LMIM
Lockheed Martin Investment Management Portfolio holdings
AUM
$2.74B
This Quarter Return
+5.1%
1 Year Return
+18.07%
3 Year Return
+58.38%
5 Year Return
+90.71%
10 Year Return
+173.39%
AUM
$2.17B
AUM Growth
+$2.17B
(+15%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
9.89%
Top 10 Holdings %
Top 10 Hldgs %
59.38%
Holding
142
New
11
Increased
30
Reduced
60
Closed
16
Top Buys
| 1 |
Vanguard Extended Market ETF
VXF
|
$84.1M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$44M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
$32.5M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
$28.1M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$26.5M |
Top Sells
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$9.05M |
| 2 |
Chubb
CB
|
$8.97M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$6.25M |
| 4 |
Bristol-Myers Squibb
BMY
|
$6.16M |
| 5 |
iShares MSCI EAFE Growth ETF
EFG
|
$5.71M |
Sector Composition
| 1 | Technology | 3.86% |
| 2 | Financials | 2.66% |
| 3 | Communication Services | 1.4% |
| 4 | Consumer Discretionary | 0.75% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Teva Pharmaceuticals
TEVA
$21.5B
| $189K | 0.01% |
10,000
-8,000
| -44% | -$151K |
|
|
SHPG
127
DELISTED
Shire pic
SHPG
| – | – |
-5,700
| Closed | -$873K |
|
|
AGN
128
DELISTED
Allergan plc
AGN
| – | – |
-16,500
| Closed | -$3.38M |
|
|
NVRO
129
DELISTED
NEVRO CORP.
NVRO
| – | – |
-8,500
| Closed | -$772K |
|
130
Travelers Companies
TRV
$62.3B
| – | – |
-23,150
| Closed | -$2.84M |
|
131
RenaissanceRe
RNR
$11.6B
| – | – |
-17,700
| Closed | -$2.39M |
|
132
Penumbra
PEN
$10.5B
| – | – |
-7,600
| Closed | -$686K |
|
133
Realty Income
O
$53B
| – | – |
-52,700
| Closed | -$3.01M |
|
134
NetEase
NTES
$85.4B
| – | – |
-6,127
| Closed | -$1.62M |
|
135
VanEck Gold Miners ETF
GDX
$19.6B
| – | – |
-150,000
| Closed | -$3.44M |
|
136
Edwards Lifesciences
EW
$47.7B
| – | – |
-8,400
| Closed | -$918K |
|
137
Evolent Health
EVH
$1.11B
| – | – |
-28,650
| Closed | -$510K |
|
138
Blackstone
BX
$131B
| – | – |
-20,000
| Closed | -$667K |
|
|
139
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-96,700
| Closed | -$6.16M |
|
140
Booking.com
BKNG
$181B
| – | – |
-600
| Closed | -$1.1M |
|
141
Aflac
AFL
$57.1B
| – | – |
-48,700
| Closed | -$3.96M |
|
142
AtriCure
ATRC
$1.73B
| – | – |
-36,250
| Closed | -$811K |
|